Table 1

SARS-CoV-2 vaccines approved for use by at least one regulatory body at the time of submission (early June 2021)71

VaccineVaccine typeDeveloper
Comirnaty (BNT162b2)mRNA basedPfizer
COVID-19 Vaccine AstraZeneca (AZD1222)AdenovirusAstraZeneca
COVID-19 Vaccine Janssen (JNJ-78436735; Ad26.COV2.S)Non-replicating viral vectorJanssen Vaccines (Johnson & Johnson)
Moderna COVID-19 Vaccine (mRNA-1273)mRNA basedModerna
Sputnik V (rAd26 and rAd5)Recombinant adenovirusGamaleya Research Institute
Sputnik Light (rAd26)Recombinant adenovirusGamaleya Research Institute
BBIBP-CorVInactivated SARS-CoV-2Sinopharm
CoronaVacInactivated SARS-CoV-2Sinovac
EpiVacCoronaPeptide (spike protein)Federal Budgetary Research Institution State Research Center of Virology and Biotechnology
Convidicea (Ad5-nCoV)Recombinant adenovirusCanSino Biologics
CovaxinInactivated SARS-CoV-2Bharat Biotech
WIBP-CorVInactivated SARS-CoV-2Sinopharm
CoviVacInactivated SARS-CoV-2Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products
ZF2001Adjuvanted protein subunitAnhui Zhifei Longcom Biopharmaceutical
QazVac (QazCovid-in)Inactivated SARS-CoV-2Research Institute for Biological Safety Problems
Inactivated SARS-CoV-2 Vaccine (Vero Cells) (yet unnamed)Inactivated SARS-CoV-2Minhai Biotechnology; Kangtai Biological Products